SEC Comment Letter 0000000000-22-012962 to Lucid Diagnostics Inc. (LUCD)

Lucid Diagnostics Inc.
Date: Dec. 1, 2022 · CIK: 0001799011 · Accession: 0000000000-22-012962

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-268560

Date

December 1, 2022

Author

Lishan Aklog

Form

UPLOAD

Company

Lucid Diagnostics Inc.

Letter

United States securities and exchange commission logo December 1, 2022 Lishan Aklog Chief Executive Officer Lucid Diagnostics Inc. One Grand Central Place, Suite 4600 New York, NY 10165 Re:Lucid Diagnostics Inc. Registration Statement on Form S-3 Filed November 25, 2022 File No. 333-268560 Dear Lishan Aklog: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Sean Healy at (202) 551-5586 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Eric Schwartz, Esq.

Show Raw Text

United States securities and exchange commission logo
December 1, 2022
Lishan Aklog
Chief Executive Officer
Lucid Diagnostics Inc.
One Grand Central Place, Suite 4600
New York, NY 10165
Re:Lucid Diagnostics Inc.
Registration Statement on Form S-3
Filed November 25, 2022
File No. 333-268560
Dear Lishan Aklog:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Sean Healy at (202) 551-5586 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Eric Schwartz, Esq.

SecProbe.io